All News

pregnant.belly-1-1314508.jpg

Spondyloarthritis Affects Pregnancy Outcomes

d Jack Cush, MD

A Danish registy has shown that the the prevalence of Spondyloarthritis (SpA) diagnosed prior to delivery has increased 5 fold in the last two decades and that SpA is associated with an increased risk of adverse pregnancy outcomes (APO).

Read Article
Behcets_disease.jpg

Apremilast Reduces Oral Ulcers in Behcet's Syndrome

d RheumNow

A multinational trial finds a statistically significant number of patients with Behçet's syndrome showed a greater reduction in the number of oral ulcers with apremilast compared with placebo.

Read Article
Spinal/SI MRI in the gen. population finds a high frequency of inflammatory and fatty MRI lesions suggestive of axSpA. MRI done in 793 volunteers < 45 yrs (49% males, 8.4% B27+). SI tJ Bone marrow edema in 17%, Vertebra BME 27% & fatty lesions in 81% https://t.co/XOzyWCyLyC

Links:

Dr. John Cush RheumNow ( View Tweet)

Norways HUNT study shows NO fracture risk with PPI use in 15,017 women and 13,241 men aged 50–85 years. PPIs were not associated with an increased risk of fracture age-adjusted HR 0.82 (0.67–1.01) for women; 1.05 (0.72–1.52) for men. https://t.co/XIAdvxGTrz

Links:

Dr. John Cush RheumNow ( View Tweet)

In the latest edition of @jrheum, our thoughts on why PMR should no longer be considered a syndrome of shoulder and pelvic girdle pain and stiffness, but rather a chronic inflammatory disease of musculotendinous structures. https://t.co/xtcZEqduhx @drdavidliew @earlyARA https://t.co/J2gqXi3PPw

Links:

Claire Owen drceowen ( View Tweet)
If you needed more info that smoking isn’t great for #rheumatoid => Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients https://t.co/kg5ns6W65l

Links:

Philip Robinson philipcrobinson ( View Tweet)

ESPOIR cohort with 172 early seronegative #RA patients finds that early csDMARD use (within 3 mos of Sx) was more likely to predict better outcomes that other prognostic risk (clinical lab or imaging) factors https://t.co/76J93mZ2NH

Links:

Dr. John Cush RheumNow ( View Tweet)

Case-control study of 821 #RA cases & comorbidities between 2009 - 2018 shows some occur after RA- epilepsy (OR 2.13), sleep apnea (1.49), pulm fibrosis (4.63); others predispose to RA, IBD (3.82), T1DM (3.07), VTE (1.80) https://t.co/OV1FsAtMH6

Links:

Dr. John Cush RheumNow ( View Tweet)

Metanalysis shows that although MTX may blunt some vaccine responses (eg Pneumococcal), the use of MTX, TNF inhibitors and other biologics should not deter vaccination as most vaccine responses are preserved despite therapy. https://t.co/KINrQMIQkt

Links:

Dr. John Cush RheumNow ( View Tweet)

We are all going to get sick, the what and why is often unknown . This may be the hardest thing you'll ever do through. How you go through it will define you and deliver you..

Dr. John Cush RheumNow ( View Tweet)

(the Fonz says) Tenacity and gratitude are 2 words to live by. - Henry Winkler

Dr. John Cush RheumNow ( View Tweet)

Me and ⁦@AdamJBrownMD⁩ of Rheumination game in the studio to do ⁦@VindicoMedEd⁩ curbside consults on GCA! Sometimes the Dx is NOT so easy!!!Stay tuned to us and ⁦@HealioRheum⁩ ⁦@AWIRGROUP⁩ ⁦@RheumNow⁩ ⁦@VasculitisFound⁩ ⁦@ramos_casals⁩ https://t.co/nnMC9r5LsH

Leonard Calabrese LCalabreseDO ( View Tweet)

Looks like the latest ACR on Air podcast is up — episode 5 — recorded during #ACR19 with host @hausmannMD and @DrBhana and myself as guests. We discuss a couple of our favorite abstracts from the meeting. @ACRheum https://t.co/WHNiHuhenZ

Dr. Paul Sufka psufka ( View Tweet)
Very cool minilecture on how to read RCTs! https://t.co/jQUawxcEr1

Links:

Dr. John Cush RheumNow ( View Tweet)

Gout Attacks Intensify with Heart Failure #cardiovascular https://t.co/LxCw8sCv5P https://t.co/ZukMrWuaeF

Links:

Rheumatology Network RheumatologyNet ( View Tweet)
Our new review article is online detailing airway inflammation and RA pathogens is - Obstructive lung diseases and risk of rheumatoid arthritis https://t.co/Nmj9Uf6isl https://t.co/ByWVI0fYwa

Links:

Jeff Sparks jeffsparks ( View Tweet)
Guselkumab, anti-IL23 in PsA Ph3 DISCOVER-1 trial in bio-naive or 30% prior TNFi = Effective at Wk 24 Safety same as with psoriasis trials. No Tb signal, No IBD signal. #ACR19 Abst0807 @_connectedcare https://t.co/d7hrn8VQO8

Links:

Dr. John Cush RheumNow ( View Tweet)

Phase 2b Bimekizumab study results in PsA shows neutralizing IL 17F and IL 17A may be a new target for LDA/treatment. https://t.co/45Vahy36g7 #ACR19 @uptoTate abs#2881

Links:

Dr. John Cush RheumNow ( View Tweet)

I didn’t realize how fast Pegloticase works. Assuming the urate burden of a gout patient, Pegloticase can degrade all the urate in the body over 5-40 days! #ACR19 3S050 Lipsky @_connectedcare

Dr. John Cush RheumNow ( View Tweet)

Panel Presentation: What’s New in Psoriatic Arthritis. So honored to join my colleagues Alexis Ogdie, Jose Scher, and Jessie Walsh to discuss the latest therapies in PsA https://t.co/Hl5r5xVygK via @YouTube #Rheumnow #ACR2019 #ACR19 #PsA

Links:

Eric Ruderman JointMD ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×